Compile Data Set for Download or QSAR

Found 63 hits with Last Name = 'midura-nowaczek' and Initial = 'k'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Serine protease 1 (Homo sapiens (Human))	BDBM50286441 ((S)-2-((S)-2-Acetylamino-4-(S)-methyl-pentanoylami...) Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O Show InChI InChI=1S/C20H38N6O5/c1-11(2)9-15(24-13(5)27)17(28)26-16(10-12(3)4)18(29)25-14(19(30)31)7-6-8-23-20(21)22/h11-12,14-16H,6-10H2,1-5H3,(H,24,27)(H,25,29)(H,26,28)(H,30,31)(H4,21,22,23)/t14-,15-,16-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Similars	Article PubMed	8	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM50286441 ((S)-2-((S)-2-Acetylamino-4-(S)-methyl-pentanoylami...) Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O Show InChI InChI=1S/C20H38N6O5/c1-11(2)9-15(24-13(5)27)17(28)26-16(10-12(3)4)18(29)25-14(19(30)31)7-6-8-23-20(21)22/h11-12,14-16H,6-10H2,1-5H3,(H,24,27)(H,25,29)(H,26,28)(H,30,31)(H4,21,22,23)/t14-,15-,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Similars	Article PubMed	8.20	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM233008 (H-D-Ser-Ala-Arg-NH-(CH2)8-NH2 (7)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCCN |r| Show InChI InChI=1S/C20H42N8O4/c1-14(27-18(31)15(22)13-29)17(30)28-16(9-8-12-26-20(23)24)19(32)25-11-7-5-3-2-4-6-10-21/h14-16,29H,2-13,21-22H2,1H3,(H,25,32)(H,27,31)(H,28,30)(H4,23,24,26)/t14-,15-,16-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	240	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM233006 (H-D-Ser-Ala-Arg-NH-(CH2)6-NH2 (5)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCN |r| Show InChI InChI=1S/C18H38N8O4/c1-12(25-16(29)13(20)11-27)15(28)26-14(7-6-10-24-18(21)22)17(30)23-9-5-3-2-4-8-19/h12-14,27H,2-11,19-20H2,1H3,(H,23,30)(H,25,29)(H,26,28)(H4,21,22,24)/t12-,13-,14-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.50E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM233009 (H-D-Ser-Ala-Arg-NH-(CH2)9-NH2 (8)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCCCN |r| Show InChI InChI=1S/C21H44N8O4/c1-15(28-19(32)16(23)14-30)18(31)29-17(10-9-13-27-21(24)25)20(33)26-12-8-6-4-2-3-5-7-11-22/h15-17,30H,2-14,22-23H2,1H3,(H,26,33)(H,28,32)(H,29,31)(H4,24,25,27)/t15-,16-,17-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM240793 (H-D-Ser-Chg-Arg-OH (4)) Show SMILES N[C@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](CCCNC(N)=N)C(O)=O)C1CCCCC1 |r| Show InChI InChI=1S/C18H34N6O5/c19-12(10-25)16(27)24-14(11-5-2-1-3-6-11)9-15(26)23-13(17(28)29)7-4-8-22-18(20)21/h11-14,25H,1-10,19H2,(H,23,26)(H,24,27)(H,28,29)(H4,20,21,22)/t12-,13-,14+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	5.02E+3	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM240790 (H-D-Ser-Phg-Arg-OH (1)) Show SMILES N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](CCCNC(N)=N)C(O)=O)c1ccccc1 |r| Show InChI InChI=1S/C18H28N6O5/c19-12(10-25)16(27)24-14(11-5-2-1-3-6-11)9-15(26)23-13(17(28)29)7-4-8-22-18(20)21/h1-3,5-6,12-14,25H,4,7-10,19H2,(H,23,26)(H,24,27)(H,28,29)(H4,20,21,22)/t12-,13+,14-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	5.70E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM240792 (H-D-Ser-homoPhe-Arg-OH (3)) Show SMILES N[C@H](CO)C(=O)N[C@H](CCc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C19H30N6O5/c20-13(11-26)16(27)24-14(9-8-12-5-2-1-3-6-12)17(28)25-15(18(29)30)7-4-10-23-19(21)22/h1-3,5-6,13-15,26H,4,7-11,20H2,(H,24,27)(H,25,28)(H,29,30)(H4,21,22,23)/t13-,14-,15-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	5.90E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM233005 (H-D-Ser-Ala-Arg-NH-(CH2)5-NH2 (4)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCN |r| Show InChI InChI=1S/C17H36N8O4/c1-11(24-15(28)12(19)10-26)14(27)25-13(6-5-9-23-17(20)21)16(29)22-8-4-2-3-7-18/h11-13,26H,2-10,18-19H2,1H3,(H,22,29)(H,24,28)(H,25,27)(H4,20,21,23)/t11-,12-,13-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	6.30E+3	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM240793 (H-D-Ser-Chg-Arg-OH (4)) Show SMILES N[C@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](CCCNC(N)=N)C(O)=O)C1CCCCC1 |r| Show InChI InChI=1S/C18H34N6O5/c19-12(10-25)16(27)24-14(11-5-2-1-3-6-11)9-15(26)23-13(17(28)29)7-4-8-22-18(20)21/h11-14,25H,1-10,19H2,(H,23,26)(H,24,27)(H,28,29)(H4,20,21,22)/t12-,13-,14+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	7.70E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM240797 (H-D-Ser-1ACH-Arg-OH (8)) Show SMILES N[C@H](CO)C(=O)NC1(CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C16H30N6O5/c17-10(9-23)12(24)22-16(6-2-1-3-7-16)14(27)21-11(13(25)26)5-4-8-20-15(18)19/h10-11,23H,1-9,17H2,(H,21,27)(H,22,24)(H,25,26)(H4,18,19,20)/t10-,11-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	7.70E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM240796 (H-D-Ser-αMePhe-Arg-OH (7)) Show SMILES CC[C@@H](N)C(=O)N[C@@](C)(Cc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C20H32N6O4/c1-3-14(21)16(27)26-20(2,12-13-8-5-4-6-9-13)18(30)25-15(17(28)29)10-7-11-24-19(22)23/h4-6,8-9,14-15H,3,7,10-12,21H2,1-2H3,(H,25,30)(H,26,27)(H,28,29)(H4,22,23,24)/t14-,15-,20+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	7.90E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM240791 (H-D-Ser-Phe-Arg-OH (2)) Show SMILES N[C@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C18H28N6O5/c19-12(10-25)15(26)24-14(9-11-5-2-1-3-6-11)16(27)23-13(17(28)29)7-4-8-22-18(20)21/h1-3,5-6,12-14,25H,4,7-10,19H2,(H,23,27)(H,24,26)(H,28,29)(H4,20,21,22)/t12-,13-,14-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	8.70E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM240794 (H-D-Ser-Cha-Arg-OH (5)) Show SMILES N[C@H](CO)C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C18H34N6O5/c19-12(10-25)15(26)24-14(9-11-5-2-1-3-6-11)16(27)23-13(17(28)29)7-4-8-22-18(20)21/h11-14,25H,1-10,19H2,(H,23,27)(H,24,26)(H,28,29)(H4,20,21,22)/t12-,13-,14-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	8.90E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM233008 (H-D-Ser-Ala-Arg-NH-(CH2)8-NH2 (7)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCCN |r| Show InChI InChI=1S/C20H42N8O4/c1-14(27-18(31)15(22)13-29)17(30)28-16(9-8-12-26-20(23)24)19(32)25-11-7-5-3-2-4-6-10-21/h14-16,29H,2-13,21-22H2,1H3,(H,25,32)(H,27,31)(H,28,30)(H4,23,24,26)/t14-,15-,16-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM233012 (H-D-Ser-Ala-Arg-NH-(CH2)4-OH (11)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCO |r| Show InChI InChI=1S/C16H33N7O5/c1-10(22-14(27)11(17)9-25)13(26)23-12(5-4-7-21-16(18)19)15(28)20-6-2-3-8-24/h10-12,24-25H,2-9,17H2,1H3,(H,20,28)(H,22,27)(H,23,26)(H4,18,19,21)/t10-,11-,12-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM240795 (H-D-Ser-homoCha-Arg-OH (6)) Show SMILES N[C@H](CO)C(=O)N[C@H](CCC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C19H36N6O5/c20-13(11-26)16(27)24-14(9-8-12-5-2-1-3-6-12)17(28)25-15(18(29)30)7-4-10-23-19(21)22/h12-15,26H,1-11,20H2,(H,24,27)(H,25,28)(H,29,30)(H4,21,22,23)/t13-,14-,15-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	1.12E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM240791 (H-D-Ser-Phe-Arg-OH (2)) Show SMILES N[C@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C18H28N6O5/c19-12(10-25)15(26)24-14(9-11-5-2-1-3-6-11)16(27)23-13(17(28)29)7-4-8-22-18(20)21/h1-3,5-6,12-14,25H,4,7-10,19H2,(H,23,27)(H,24,26)(H,28,29)(H4,20,21,22)/t12-,13-,14-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	1.21E+4	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM240796 (H-D-Ser-αMePhe-Arg-OH (7)) Show SMILES CC[C@@H](N)C(=O)N[C@@](C)(Cc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C20H32N6O4/c1-3-14(21)16(27)26-20(2,12-13-8-5-4-6-9-13)18(30)25-15(17(28)29)10-7-11-24-19(22)23/h4-6,8-9,14-15H,3,7,10-12,21H2,1-2H3,(H,25,30)(H,26,27)(H,28,29)(H4,22,23,24)/t14-,15-,20+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.25E+4	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM240797 (H-D-Ser-1ACH-Arg-OH (8)) Show SMILES N[C@H](CO)C(=O)NC1(CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C16H30N6O5/c17-10(9-23)12(24)22-16(6-2-1-3-7-16)14(27)21-11(13(25)26)5-4-8-20-15(18)19/h10-11,23H,1-9,17H2,(H,21,27)(H,22,24)(H,25,26)(H4,18,19,20)/t10-,11-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.50E+4	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM233011 (H-D-Ser-Ala-Arg-NH-(CH2)3-OH (10)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCO |r| Show InChI InChI=1S/C15H31N7O5/c1-9(21-13(26)10(16)8-24)12(25)22-11(4-2-5-20-15(17)18)14(27)19-6-3-7-23/h9-11,23-24H,2-8,16H2,1H3,(H,19,27)(H,21,26)(H,22,25)(H4,17,18,20)/t9-,10-,11-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.50E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM240792 (H-D-Ser-homoPhe-Arg-OH (3)) Show SMILES N[C@H](CO)C(=O)N[C@H](CCc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C19H30N6O5/c20-13(11-26)16(27)24-14(9-8-12-5-2-1-3-6-12)17(28)25-15(18(29)30)7-4-10-23-19(21)22/h1-3,5-6,13-15,26H,4,7-11,20H2,(H,24,27)(H,25,28)(H,29,30)(H4,21,22,23)/t13-,14-,15-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	1.61E+4	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM240795 (H-D-Ser-homoCha-Arg-OH (6)) Show SMILES N[C@H](CO)C(=O)N[C@H](CCC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C19H36N6O5/c20-13(11-26)16(27)24-14(9-8-12-5-2-1-3-6-12)17(28)25-15(18(29)30)7-4-10-23-19(21)22/h12-15,26H,1-11,20H2,(H,24,27)(H,25,28)(H,29,30)(H4,21,22,23)/t13-,14-,15-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	1.81E+4	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM240794 (H-D-Ser-Cha-Arg-OH (5)) Show SMILES N[C@H](CO)C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C18H34N6O5/c19-12(10-25)15(26)24-14(9-11-5-2-1-3-6-11)16(27)23-13(17(28)29)7-4-8-22-18(20)21/h11-14,25H,1-10,19H2,(H,23,27)(H,24,26)(H,28,29)(H4,20,21,22)/t12-,13-,14-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	1.98E+4	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM240791 (H-D-Ser-Phe-Arg-OH (2)) Show SMILES N[C@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C18H28N6O5/c19-12(10-25)15(26)24-14(9-11-5-2-1-3-6-11)16(27)23-13(17(28)29)7-4-8-22-18(20)21/h1-3,5-6,12-14,25H,4,7-10,19H2,(H,23,27)(H,24,26)(H,28,29)(H4,20,21,22)/t12-,13-,14-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	2.29E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM240790 (H-D-Ser-Phg-Arg-OH (1)) Show SMILES N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](CCCNC(N)=N)C(O)=O)c1ccccc1 |r| Show InChI InChI=1S/C18H28N6O5/c19-12(10-25)16(27)24-14(11-5-2-1-3-6-11)9-15(26)23-13(17(28)29)7-4-8-22-18(20)21/h1-3,5-6,12-14,25H,4,7-10,19H2,(H,23,26)(H,24,27)(H,28,29)(H4,20,21,22)/t12-,13+,14-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.29E+4	n/a	n/a	n/a	n/a	n/a	n/a	8.4	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM240792 (H-D-Ser-homoPhe-Arg-OH (3)) Show SMILES N[C@H](CO)C(=O)N[C@H](CCc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C19H30N6O5/c20-13(11-26)16(27)24-14(9-8-12-5-2-1-3-6-12)17(28)25-15(18(29)30)7-4-10-23-19(21)22/h1-3,5-6,13-15,26H,4,7-11,20H2,(H,24,27)(H,25,28)(H,29,30)(H4,21,22,23)/t13-,14-,15-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	2.39E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM240797 (H-D-Ser-1ACH-Arg-OH (8)) Show SMILES N[C@H](CO)C(=O)NC1(CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C16H30N6O5/c17-10(9-23)12(24)22-16(6-2-1-3-7-16)14(27)21-11(13(25)26)5-4-8-20-15(18)19/h10-11,23H,1-9,17H2,(H,21,27)(H,22,24)(H,25,26)(H4,18,19,20)/t10-,11-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.62E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM240790 (H-D-Ser-Phg-Arg-OH (1)) Show SMILES N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](CCCNC(N)=N)C(O)=O)c1ccccc1 |r| Show InChI InChI=1S/C18H28N6O5/c19-12(10-25)16(27)24-14(11-5-2-1-3-6-11)9-15(26)23-13(17(28)29)7-4-8-22-18(20)21/h1-3,5-6,12-14,25H,4,7-10,19H2,(H,23,26)(H,24,27)(H,28,29)(H4,20,21,22)/t12-,13+,14-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.63E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM240795 (H-D-Ser-homoCha-Arg-OH (6)) Show SMILES N[C@H](CO)C(=O)N[C@H](CCC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C19H36N6O5/c20-13(11-26)16(27)24-14(9-8-12-5-2-1-3-6-12)17(28)25-15(18(29)30)7-4-10-23-19(21)22/h12-15,26H,1-11,20H2,(H,24,27)(H,25,28)(H,29,30)(H4,21,22,23)/t13-,14-,15-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	2.72E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM240796 (H-D-Ser-αMePhe-Arg-OH (7)) Show SMILES CC[C@@H](N)C(=O)N[C@@](C)(Cc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C20H32N6O4/c1-3-14(21)16(27)26-20(2,12-13-8-5-4-6-9-13)18(30)25-15(17(28)29)10-7-11-24-19(22)23/h4-6,8-9,14-15H,3,7,10-12,21H2,1-2H3,(H,25,30)(H,26,27)(H,28,29)(H4,22,23,24)/t14-,15-,20+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.82E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM233007 (H-D-Ser-Ala-Arg-NH-(CH2)7-NH2 (6)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCN |r| Show InChI InChI=1S/C19H40N8O4/c1-13(26-17(30)14(21)12-28)16(29)27-15(8-7-11-25-19(22)23)18(31)24-10-6-4-2-3-5-9-20/h13-15,28H,2-12,20-21H2,1H3,(H,24,31)(H,26,30)(H,27,29)(H4,22,23,25)/t13-,14-,15-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	3.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM240794 (H-D-Ser-Cha-Arg-OH (5)) Show SMILES N[C@H](CO)C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C18H34N6O5/c19-12(10-25)15(26)24-14(9-11-5-2-1-3-6-11)16(27)23-13(17(28)29)7-4-8-22-18(20)21/h11-14,25H,1-10,19H2,(H,23,27)(H,24,26)(H,28,29)(H4,20,21,22)/t12-,13-,14-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	3.09E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM233005 (H-D-Ser-Ala-Arg-NH-(CH2)5-NH2 (4)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCN |r| Show InChI InChI=1S/C17H36N8O4/c1-11(24-15(28)12(19)10-26)14(27)25-13(6-5-9-23-17(20)21)16(29)22-8-4-2-3-7-18/h11-13,26H,2-10,18-19H2,1H3,(H,22,29)(H,24,28)(H,25,27)(H4,20,21,23)/t11-,12-,13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	3.70E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Serine protease 1 (Homo sapiens (Human))	BDBM240793 (H-D-Ser-Chg-Arg-OH (4)) Show SMILES N[C@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](CCCNC(N)=N)C(O)=O)C1CCCCC1 |r| Show InChI InChI=1S/C18H34N6O5/c19-12(10-25)16(27)24-14(11-5-2-1-3-6-11)9-15(26)23-13(17(28)29)7-4-8-22-18(20)21/h11-14,25H,1-10,19H2,(H,23,26)(H,24,27)(H,28,29)(H4,20,21,22)/t12-,13-,14+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	4.84E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.5	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM233008 (H-D-Ser-Ala-Arg-NH-(CH2)8-NH2 (7)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCCN |r| Show InChI InChI=1S/C20H42N8O4/c1-14(27-18(31)15(22)13-29)17(30)28-16(9-8-12-26-20(23)24)19(32)25-11-7-5-3-2-4-6-10-21/h14-16,29H,2-13,21-22H2,1H3,(H,25,32)(H,27,31)(H,28,30)(H4,23,24,26)/t14-,15-,16-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	8.70E+4	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM233009 (H-D-Ser-Ala-Arg-NH-(CH2)9-NH2 (8)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCCCN |r| Show InChI InChI=1S/C21H44N8O4/c1-15(28-19(32)16(23)14-30)18(31)29-17(10-9-13-27-21(24)25)20(33)26-12-8-6-4-2-3-5-7-11-22/h15-17,30H,2-14,22-23H2,1H3,(H,26,33)(H,28,32)(H,29,31)(H4,24,25,27)/t15-,16-,17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	9.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM233006 (H-D-Ser-Ala-Arg-NH-(CH2)6-NH2 (5)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCN |r| Show InChI InChI=1S/C18H38N8O4/c1-12(25-16(29)13(20)11-27)15(28)26-14(7-6-10-24-18(21)22)17(30)23-9-5-3-2-4-8-19/h12-14,27H,2-11,19-20H2,1H3,(H,23,30)(H,25,29)(H,26,28)(H4,21,22,24)/t12-,13-,14-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.81E+5	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM233007 (H-D-Ser-Ala-Arg-NH-(CH2)7-NH2 (6)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCN |r| Show InChI InChI=1S/C19H40N8O4/c1-13(26-17(30)14(21)12-28)16(29)27-15(8-7-11-25-19(22)23)18(31)24-10-6-4-2-3-5-9-20/h13-15,28H,2-12,20-21H2,1H3,(H,24,31)(H,26,30)(H,27,29)(H4,22,23,25)/t13-,14-,15-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.44E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM240794 (H-D-Ser-Cha-Arg-OH (5)) Show SMILES N[C@H](CO)C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C18H34N6O5/c19-12(10-25)15(26)24-14(9-11-5-2-1-3-6-11)16(27)23-13(17(28)29)7-4-8-22-18(20)21/h11-14,25H,1-10,19H2,(H,23,27)(H,24,26)(H,28,29)(H4,20,21,22)/t12-,13-,14-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	2.47E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM240796 (H-D-Ser-αMePhe-Arg-OH (7)) Show SMILES CC[C@@H](N)C(=O)N[C@@](C)(Cc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C20H32N6O4/c1-3-14(21)16(27)26-20(2,12-13-8-5-4-6-9-13)18(30)25-15(17(28)29)10-7-11-24-19(22)23/h4-6,8-9,14-15H,3,7,10-12,21H2,1-2H3,(H,25,30)(H,26,27)(H,28,29)(H4,22,23,24)/t14-,15-,20+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.76E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM233009 (H-D-Ser-Ala-Arg-NH-(CH2)9-NH2 (8)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCCCN |r| Show InChI InChI=1S/C21H44N8O4/c1-15(28-19(32)16(23)14-30)18(31)29-17(10-9-13-27-21(24)25)20(33)26-12-8-6-4-2-3-5-7-11-22/h15-17,30H,2-14,22-23H2,1H3,(H,26,33)(H,28,32)(H,29,31)(H4,24,25,27)/t15-,16-,17-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.93E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM240793 (H-D-Ser-Chg-Arg-OH (4)) Show SMILES N[C@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](CCCNC(N)=N)C(O)=O)C1CCCCC1 |r| Show InChI InChI=1S/C18H34N6O5/c19-12(10-25)16(27)24-14(11-5-2-1-3-6-11)9-15(26)23-13(17(28)29)7-4-8-22-18(20)21/h11-14,25H,1-10,19H2,(H,23,26)(H,24,27)(H,28,29)(H4,20,21,22)/t12-,13-,14+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	3.22E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM233007 (H-D-Ser-Ala-Arg-NH-(CH2)7-NH2 (6)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCCCCN |r| Show InChI InChI=1S/C19H40N8O4/c1-13(26-17(30)14(21)12-28)16(29)27-15(8-7-11-25-19(22)23)18(31)24-10-6-4-2-3-5-9-20/h13-15,28H,2-12,20-21H2,1H3,(H,24,31)(H,26,30)(H,27,29)(H4,22,23,25)/t13-,14-,15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	3.64E+5	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM240797 (H-D-Ser-1ACH-Arg-OH (8)) Show SMILES N[C@H](CO)C(=O)NC1(CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C16H30N6O5/c17-10(9-23)12(24)22-16(6-2-1-3-7-16)14(27)21-11(13(25)26)5-4-8-20-15(18)19/h10-11,23H,1-9,17H2,(H,21,27)(H,22,24)(H,25,26)(H4,18,19,20)/t10-,11-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	3.95E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM240795 (H-D-Ser-homoCha-Arg-OH (6)) Show SMILES N[C@H](CO)C(=O)N[C@H](CCC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C19H36N6O5/c20-13(11-26)16(27)24-14(9-8-12-5-2-1-3-6-12)17(28)25-15(18(29)30)7-4-10-23-19(21)22/h12-15,26H,1-11,20H2,(H,24,27)(H,25,28)(H,29,30)(H4,21,22,23)/t13-,14-,15-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	4.51E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM240790 (H-D-Ser-Phg-Arg-OH (1)) Show SMILES N[C@@H](CO)C(=O)N[C@@H](CC(=O)N[C@H](CCCNC(N)=N)C(O)=O)c1ccccc1 |r| Show InChI InChI=1S/C18H28N6O5/c19-12(10-25)16(27)24-14(11-5-2-1-3-6-11)9-15(26)23-13(17(28)29)7-4-8-22-18(20)21/h1-3,5-6,12-14,25H,4,7-10,19H2,(H,23,26)(H,24,27)(H,28,29)(H4,20,21,22)/t12-,13+,14-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	4.88E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM240791 (H-D-Ser-Phe-Arg-OH (2)) Show SMILES N[C@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C18H28N6O5/c19-12(10-25)15(26)24-14(9-11-5-2-1-3-6-11)16(27)23-13(17(28)29)7-4-8-22-18(20)21/h1-3,5-6,12-14,25H,4,7-10,19H2,(H,23,27)(H,24,26)(H,28,29)(H4,20,21,22)/t12-,13-,14-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	5.44E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM233012 (H-D-Ser-Ala-Arg-NH-(CH2)4-OH (11)) Show SMILES C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCCO |r| Show InChI InChI=1S/C16H33N7O5/c1-10(22-14(27)11(17)9-25)13(26)23-12(5-4-7-21-16(18)19)15(28)20-6-2-3-8-24/h10-12,24-25H,2-9,17H2,1H3,(H,20,28)(H,22,27)(H,23,26)(H4,18,19,21)/t10-,11-,12-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	5.45E+5	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Medical University of Bialystok					Assay Description Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...				J Enzyme Inhib Med Chem 25: 139-42 (2010) Article DOI: 10.3109/14756360903049042 BindingDB Entry DOI: 10.7270/Q23R0RR3
					More data for this Ligand-Target Pair
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM240792 (H-D-Ser-homoPhe-Arg-OH (3)) Show SMILES N[C@H](CO)C(=O)N[C@H](CCc1ccccc1)C(=O)N[C@H](CCCNC(N)=N)C(O)=O |r| Show InChI InChI=1S/C19H30N6O5/c20-13(11-26)16(27)24-14(9-8-12-5-2-1-3-6-12)17(28)25-15(18(29)30)7-4-10-23-19(21)22/h1-3,5-6,13-15,26H,4,7-11,20H2,(H,24,27)(H,25,28)(H,29,30)(H4,21,22,23)/t13-,14-,15-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	5.66E+5	n/a	n/a	n/a	n/a	n/a	n/a	8.8	n/a
Medical University of Bialystok					Assay Description Buffer and 0.1 mL of enzyme solution was added to 0.2 mL of examined compounddissolved in 0.15 M NaCl (as control 0.15 M NaCl). The buffer and the en...				J Enzyme Inhib Med Chem 28: 639-43 (2013) Article DOI: 10.3109/14756366.2011.651463 BindingDB Entry DOI: 10.7270/Q2HQ3XTK
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 63 total )  |  Next  |  Last  >>

Jump to: